Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$31.44M
EBITDA Margin
2.14%
TTM Avg
1.67%
3Y Avg
3.35%
5Y Avg
2.87%
Market Cap
$31.26M
EBITDA Margin
-2671.72%
TTM Avg
-3785.12%
3Y Avg
-14400.08%
5Y Avg
-14400.08%
Market Cap
$31.44M
EBITDA Margin
-108.41%
TTM Avg
-31.49%
3Y Avg
5.24%
5Y Avg
21.14%
Market Cap
$31.15M
EBITDA Margin
-5.74%
TTM Avg
-12.14%
3Y Avg
-35.62%
5Y Avg
-63.06%
Market Cap
$32.76M
EBITDA Margin
-29.82%
TTM Avg
-228.84%
3Y Avg
-176.67%
5Y Avg
-120.12%
Market Cap
$30.31M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | $31.65M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.14% | 1.67% | 3.35% | 2.87% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.26M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.26M | -2671.72% | -3785.12% | -14400.08% | -14400.08% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.44M | -108.41% | -31.49% | 5.24% | 21.14% |
| MDxHealth S.A. (MDXH)vs › | $31.15M | -5.74% | -12.14% | -35.62% | -63.06% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | -29.82% | -228.84% | -176.67% | -120.12% |
| HeartBeam, Inc. (BEAT)vs › | $33.25M | 31.08% | 27.03% | 24.58% | 21.46% |
| GridAI Technologies Corp. (GRDX)vs › | $30.31M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| CervoMed Inc. (CRVO)vs › | $30.18M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
